ONE Bio Signs Japanese Distribution Agreement With Sanyo

   ONE Bio, Corp. ("ONE" or the "Company") (OTCBB: ONBI), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, today announced that it has signed a distribution agreement with Sanyo Trading Co. Ltd. ("Sanyo"), one of the largest international trading companies in Japan. The agreement further expands ONE's distribution network in Japan.

Under the terms of the agreement, ONE will produce a new private-label line of organic products for distribution to Sanyo's network of supermarket chains, which ranges from large, moderately priced chains such as Jusco, Ito Yokado, Seiyu (owned by Wal-Mart) and Daiei to smaller neighborhood food shops including Foodex, Y's Mart, and Ogikubo.

The new contract follows the success of ONE's private-label brand for Kobe Bussan, a leading Japanese supermarket operator. Since launching the private-label line in March 2010, ONE's Organic Products ("OP") division has achieved 20% sales growth in Japan. Japan currently accounts for over 30% of the OP division's sales, with the strong consumer demand for its products fueled by the high quality-control standards utilized by the Company in its organic vegetable selection and manufacturing processes. ONE's organic vegetable products are Japanese Agricultural Standard ("JAS") Gold-certified, the highest certification for organic products in Japan.

"Japan continues to be our strongest export market. The Japanese market for organic food and drinks is the largest in the Asia-Pacific region, and Japanese consumers benefit from the highest disposable income in Asia. Our rapid market acceptance in Japan strongly reflects the quality and safety of our products. We appreciate the confidence Kobe, Sanyo and other Japanese retailers have entrusted to us," stated ONE's CEO, Marius Silvasan.

Mr. Silvasan continued, "According to Datamonitor, the global organic food market grew by 9.7 percent in 2009 to reach $60 billion. It is anticipated that by 2014, this market could reach $96.6 billion in value, an increase of 60.7 percent from 2009. We are committed to aggressively adding distribution channels to take advantage of this rapidly growing global demand."

About ONE Bio, Corp. ONE Bio, Corp. ("ONE") (OTCBB: ONBI) (www.onehcorp.com), headquartered in Miami, FL, is an innovative company utilizing patented green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on the Asia-Pacific region and the United States. Key products include widely recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages. ONE has experienced solid organic growth driven by a robust demand for its products in China, Japan and the United States.

About Sanyo Trading Co. Ltd. Sanyo Trading was established in 1947 in Japan. The Company employs over 200 employees and has a turnover volume of $286 million Euro. Sanyo Trading is headquartered in Tokyo with offices in Osaka and Nagoya, and international offices in New York, Detroit, Cincinnati, Vancouver, Tianjin, Shanghai, Shenzhen, Bangkok, Melbourne, Hanoi, Ho Chi Minh City, and Maastricht, Netherlands.

This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE Bio, Corp. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. These risks and other factors are detailed in the Company's regular filings with the U.S. Securities and Exchange Commission. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and ONE Bio, Corp. does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Company Contact: Jeanne Chan Senior VP Tel. [phone] [e-mail] Investor Relations Contact: Investor Relations & Corporate Communications 888-676-4445 [e-mail] Dave Gentry U.S. RedChip Companies, Inc. Tel: [phone], Ext. 104 Email: [e-mail] Jing Zhang China RedChip Beijing Representative Office Tel: [phone] Web: http://www.RedChip.com